“Blind faith” - it’s quite a dilemma I think for some shareholders - myself included. I seriously believe in the remote monitoring & the underlying product that supports it-and have since day dot. I haven’t sold a share in 3 years. It has such potential - and did even before COVID. However I have major reservations over the quality & integrity of management & their ability to achieve that potential. Their track record to date has been characterised by mid-step after mis-step & less than transparent behaviours. How do shareholders reconcile this? What a trade off.! The ASX delist - privatisation - list Nasdaq process requires the CEO & directors to do the “right thing” by all shareholders as their is limited recourse once delisted locally. I have a major concern about the comms / updates / transparency during the non-listed period which is why some sort of update should be a priority.
- Forums
- ASX - By Stock
- GMV
- Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing, page-572
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)